Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF<sup>high</sup> neutrophils.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29191879.
- Also identified by DOI 10.1126/science.aal5081 and PMC identifier 6343476.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bone marrow-derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients (<i>n</i> = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn<sup>+</sup>) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrating SiglecF<sup>high</sup> neutrophils, which exhibit cancer-promoting properties. Experimentally reducing Ocn<sup>+</sup> cell numbers suppresses the neutrophil response and lung tumor outgrowth. These observations posit osteoblasts as remote regulators of lung cancer and identify SiglecF<sup>high</sup> neutrophils as myeloid cell effectors of the osteoblast-driven protumoral response.
Medical subject headings
- Adenocarcinoma
- Antigens, CD
- Antigens, Differentiation, Myelomonocytic
- Bone and Bones
- Lectins
- Lung Neoplasms
- Neutrophil Infiltration
- Neutrophils
- Osteoblasts